10x Genomics
259 hedge funds and large institutions have $2.05B invested in 10x Genomics in 2024 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 113 increasing their positions, 75 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
42% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 62
47% less capital invested
Capital invested by funds: $3.88B → $2.05B (-$1.84B)
Holders
259
Holding in Top 10
4
Calls
$4.01M
Puts
$2.37M
Top Buyers
| 1 | +$79.3M | |
| 2 | +$66.2M | |
| 3 | +$66M | |
| 4 |
UBS AM
Chicago,
Illinois
|
+$46.9M |
| 5 |
GIM
Generation Investment Management
London,
United Kingdom
|
+$38.5M |
Top Sellers
| 1 | -$123M | |
| 2 | -$29.4M | |
| 3 | -$27.5M | |
| 4 |
Sands Capital Management
Arlington,
Virginia
|
-$27.4M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$26.5M |